| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/12/2002 | US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/07/2002 | WO2002009697A1 Highly purified simvastatin compositions |
| 02/07/2002 | US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics |
| 02/07/2002 | DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives |
| 02/07/2002 | CA2419206A1 Highly purified simvastatin compositions |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/05/2002 | US6344583 Oxidation of ketones to esters using a tin substituted zeolite beta |
| 02/05/2002 | US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/31/2002 | WO2002008209A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 01/31/2002 | US20020013360 Protease inhibitors |
| 01/30/2002 | CN1333652A Cyclohexenone oxime ether/(glyphosates/gluphosinates) suspension concentrates |
| 01/29/2002 | USRE37534 Pharmaceutical compositions |
| 01/29/2002 | US6342639 Processes for preparing 3-Arylsulfur hydroxamic acids |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/24/2002 | WO2002006266A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives |
| 01/24/2002 | WO2002006262A1 Process for producing hydroxylactone |
| 01/24/2002 | WO2001081291A3 The oxidation of ketones to esters using a tin substituted zeolite beta |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/23/2002 | EP1173420A2 Heterocyclic compounds having antitumor activity |
| 01/23/2002 | EP0833826B1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 01/22/2002 | US6340739 Polyamide and process for producing the same |
| 01/22/2002 | US6340702 Neuraminic acid derivatives, their preparation and their medical use |
| 01/22/2002 | US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 01/17/2002 | WO2002004436A1 Processes for the preparation of pyrone compounds |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | CN1331675A Novel herbicides |
| 01/15/2002 | US6339162 Process for the preparation of tetrahydropyran derivatives |
| 01/15/2002 | CA2164411C Process for the isolation of lovastatin |
| 01/10/2002 | WO2002002547A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 01/10/2002 | WO2002002486A1 Process for the preparation of polyhydric alcohols |
| 01/10/2002 | WO2001036368A3 Metathesis syntheses of pheromones or their components |
| 01/10/2002 | US20020004602 Asymmetric cycloaddition reactions |
| 01/10/2002 | US20020004505 Bactericides; anticancer agents |
| 01/10/2002 | CA2412874A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 01/09/2002 | EP1170352A2 Diflourovinyl compound, liquid crystal composition and liquid crystal display |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169291A1 METHODS FOR PRODUCING $g(a)-ACYLOXY CARBONYL COMPOUNDS FROM ENOL ESTER EPOXIDES |
| 01/09/2002 | EP0863886B1 Fluoromethoxyacrylic acid derivatives and their use as pest control agents |
| 01/09/2002 | CN1330070A Perfume parent |
| 01/08/2002 | US6337411 Muscular disorders |
| 01/08/2002 | US6337401 Fluoromethoxyacrylic acid derivatives and their use as pest control agents |
| 01/03/2002 | WO2002000615A2 Process for the isolation of lovastatin |
| 01/03/2002 | WO2002000590A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 01/03/2002 | WO2001054501A3 Herbicidal composition |
| 01/03/2002 | US20020002288 Using a base in solvent |
| 01/03/2002 | CA2412566A1 Process for the isolation of lovastatin |
| 01/02/2002 | EP1167362A1 Fragance precursors |
| 01/02/2002 | EP1165541A1 Dimeric compounds and as inhibitors of neuraminidase |
| 01/02/2002 | EP1165540A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/02/2002 | EP1165538A2 Process for the preparation of alpha-methylenelactones and alpha-substituted hydrocarbylidene lactones |
| 01/01/2002 | US6335353 3-hydroxypyridin-4-one derivative; iron deficiency anemia and thalassemia treatment |
| 01/01/2002 | CA2024849C 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098288A1 Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides |
| 12/27/2001 | WO2001098238A2 Catalytic hydrogenation of ketones and aldehydes |
| 12/27/2001 | WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | WO2001029020A3 Neuraminidase inhibitors |
| 12/27/2001 | US20010056088 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | CA2408412A1 Catalytic hydrogenation of ketones and aldehydes |
| 12/25/2001 | US6333441 Preparation of cis—olefins |
| 12/25/2001 | CA2243592C Method of production of lovastatin |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | US20010053859 Reacting lovastatin with organic boronate compound |
| 12/20/2001 | DE10128250A1 New hydrolytically stable glycolipid compounds having an alpha-C, N or S glycoside bond, useful as anticancer agents and immunostimulants |
| 12/20/2001 | DE10030094A1 New phenyl-substituted 5,6-dihydro-pyrone derivatives, useful as total or selective herbicides, insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents |
| 12/20/2001 | CA2411805A1 Serine protease inhibitors |
| 12/19/2001 | EP1163203A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/18/2001 | US6331650 Method for manufacturing aminoalcohol |
| 12/18/2001 | US6331641 Process for producing simvastatin |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/12/2001 | EP1161437A1 Phosphabenzene compounds and their use as ligands for hydroformylation catalysts |
| 12/12/2001 | EP1161427A1 Improved process for asymmetric hydrogenation |
| 12/12/2001 | EP1161233A2 Lxr modulators |
| 12/12/2001 | EP0748307B1 Skin lightening compositions |
| 12/06/2001 | WO2001092991A2 Design of polyketide synthase genes |
| 12/06/2001 | US20010049387 Use in the treatment of cancer, as tubulin polymerizers and as microtubule stabilization agents. |
| 12/05/2001 | EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 12/05/2001 | CN1075809C Novel vitamin D analogues |
| 12/04/2001 | US6326399 O-benzyloxime ethers and crop protection agents containing these compounds |
| 12/04/2001 | CA2000553C Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof |
| 11/28/2001 | EP1157987A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 11/28/2001 | EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 11/28/2001 | CN1324352A 2-phenylpyran-4-one derivatives |
| 11/27/2001 | US6323347 Used for dehydrocyclization reaction of a diol under a gas phase to form lactone; activity, long lifetime and high selectivity of products |
| 11/27/2001 | CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides |
| 11/22/2001 | WO2001087876A1 Sialic acid derivatives |
| 11/22/2001 | WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents |
| 11/22/2001 | DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases |
| 11/22/2001 | CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents |
| 11/21/2001 | EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |